NKA Bio: Funding, Investors & Team (Oct 2026)
NKA Bio is a medical device company that improves trauma care by solving shock. The company is focused on its primary product, the NKA01 for trauma resuscitation. The early-stage pipeline in development includes programs for septic shock, acute lung injury, and heart attack resuscitation.
NKA Bio has raised $30k across 1 funding round on record, the most recent a Seed of $30k announced in Apr 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NKA Bio Company Profile and Key Stats
Latest funding round on record: Apr 2023.
NKA Bio Funding Rounds
NKA Bio Founders and Leadership Team
No contact details are on record for this team yet.
NKA Bio Funding Compared to Other Biotechnology Startups
NKA Bio's latest round of $30k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NKA Bio in Biotechnology and Baltimore
Companies Similar to NKA Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
NKA Bio Funding FAQs
What does NKA Bio do?
NKA Bio is a medical device company that improves trauma care by solving shock. The company is focused on its primary product, the NKA01 for trauma resuscitation. The early-stage pipeline in development includes programs for septic shock, acute lung injury, and heart attack resuscitation.
How much funding has NKA Bio raised?
NKA Bio has raised $30k across 1 round on record. The most recent is a Seed of $30k announced in Apr 2023.
When did NKA Bio last raise funding?
NKA Bio's most recent funding round on record is a Seed of $30k, announced in Apr 2023.
Who is the CEO of NKA Bio?
Susan Gann Hibbs is listed as CEO at NKA Bio.
Where is NKA Bio headquartered?
NKA Bio is based in Baltimore, Maryland, United States.
How many employees does NKA Bio have?
NKA Bio is in the 1-10 employee band.
How does NKA Bio's funding compare to other Biotechnology startups?
NKA Bio's latest round of $30k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's NKA Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NKA Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.